The Artisan Mid Cap Value Fund has sold its stake in Bio-Rad Laboratories (BIO) during the fourth quarter. The move reflects a strategic shift in the fund's portfolio.
- Artisan Mid Cap Value Fund sold Bio-Rad Laboratories (BIO) in Q4 2025.
- The sale is part of the fund's portfolio rebalancing strategy.
- Bio-Rad operates in the healthcare sector, focusing on life science research and clinical diagnostics.
- The move is unlikely to cause major market disruptions.
- Investors may watch for further changes in the fund's holdings.
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.